Astellas Pharma has initiated a global campaign to address the critical issue of delayed bladder cancer diagnoses. In collaboration with the World Bladder Cancer Patient Coalition (WBCPC) and behavioral scientists, the company aims to understand the barriers preventing individuals from seeking timely medical attention for bladder cancer symptoms.
Bladder cancer often goes undetected until advanced stages, significantly reducing survival rates. By exploring cultural, emotional, and societal factors influencing patient behavior, Astellas seeks to develop strategies that encourage earlier diagnosis and improve outcomes for those affected by this disease.
This initiative underscores Astellas’ commitment to patient-centric approaches and aligns with the broader efforts within the Leiden Bio Science Park to enhance healthcare through innovative research and collaboration.
Read more here
Starting Friday, November 14 at 4:00 p.m., two temporary closures (in place for the duration of the Plesmanlaan project, until approximately Q3 2027) will be implemented for...
24 October 2025, Over the past 20 years, Dutch hospitals have filed 559 European patent applications. This emerges from a new study by the European Patent Office and Fraunhofer...
Leiden, 24 October 2025 at 3:03 PMResearchers at LUMC, together with colleagues from the University of Florida, have identified hundreds of proteins in the blood that provide...